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ART ICLE Open Ac ce s s
ESCRT-III is necessary for the integrity of the
nuclear envelope in micronuclei but is
aberrant at ruptured micronuclear
envelopes generating damage
Jessica Willan1,2, Alexa J. Cleasby1, Neftali Flores-Rodriguez3, Flavia Stefani4, Cinzia Rinaldo5,6, Alessandra Pisciottani5,
Emma Grant1,2, Philip Woodman 4, Helen E. Bryant 2 and Barbara Ciani 1
Abstract
Micronuclei represent the cellular attempt to compartmentalize DNA to maintain genomic integrity threatened by
mitotic errors and genotoxic events. Some micronuclei show aberrant nuclear envelopes (NEs) that collapse,
generating damaged DNA that can promote complex genome alterations. However, ruptured micronuclei also
provide a pool of cytosolic DNA that can stimulate antitumor immunity, revealing the complexity of micronuclear
impact on tumor progression. The ESCRT-III (Endosomal Sorting Complex Required for Transport-III) complex ensures
NE reseals during late mitosis and is repaired in interphase. Therefore, ESCRT-III activity maybe crucial for maintaining
the integrity of other genomic structures enclosed by a NE. ESCRT-III activity at the NE is coordinated by the subunit
CHMP7. We show that CHMP7 and ESCRT-III protect against the genomic instability associated with micronuclei
formation. Loss of ESCRT-III activity increases the population of micronuclei with ruptured NEs, revealing that its NE
repair activity is also necessary to maintain micronuclei integrity. Surprisingly, aberrant accumulation of ESCRT-III are
found at the envelope of most acentric collapsed micronuclei, suggesting that ESCRT-III is not recycled efﬁciently from
these structures. Moreover, CHMP7 depletion relieves micronuclei from the aberrant accumulations of ESCRT-III.
CHMP7-depleted cells display a reduction in micronuclei containing the DNA damage marker RPA and a sensor of
cytosolic DNA. Thus, ESCRT-III activity appears to protect from the consequence of genomic instability in a
dichotomous fashion: ESCRT-III membrane repair activity prevents the occurrence of micronuclei with weak envelopes,
but the aberrant accumulation of ESCRT-III on a subset of micronuclei appears to exacerbate DNA damage and sustain
proinﬂammatory pathways.
Introduction
Micronuclei are cytosolic chromatin structures that are
compartmentalized by a nuclear envelope (NE). They are
a measure of chromosome instability and thus are hall-
marks of cancer cells. Micronuclei originate during
mitosis, either because whole chromosomes separate
aberrantly, or because DNA damage generates chromo-
somal fragments that lack centromeres and thus fail to
align at the metaphase plate1. The resulting structures
rebuild their own NE away from the main chromatin
mass. Micronuclei persist through multiple cell divisions,
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but their NE can collapse within the G2 phase of the cell
cycle2. The cause of such collapse remains unclear, but
correlates with a lack of nuclear lamina integrity2. Such
loss of micronuclear compartmentalization causes cyto-
solic enzymes to enter the micronucleus, generating fur-
ther DNA damage and chromosome pulverization3. A
micronucleus can reincorporate in the primary nucleus,
creating the conditions for DNA fragments to rejoin the
main genome at random locations (chromothripsis).
Therefore, an intact NE around a micronucleus maintains
the integrity of its genetic material4–6 and thereby pro-
tects against chromothripsis.
NE integrity at the primary nucleus is ensured by
ESCRT-III, a universal membrane-remodeling complex.
Speciﬁcally, ESCRT-III seals nuclear membranes during
late mitosis and repairs mechanical rupture of the NE
during interphase7–10. Core ESCRT-III subunits, includ-
ing the critical membrane-deforming polymer CHMP4B
(Charged Multivesicular body Protein 4B), are recruited
by CHMP711, a specialized ESCRT-III subunit that is
targeted to NE gaps by associating with the chromatin
binding protein LEM212. ESCRT-III seals these gaps by
supporting reverse-topology membrane scission13.
ESCRT-III activity at the NE is short-lived, and is regu-
lated by the AAA ATPase, VPS4. VPS4 remodels ESCRT-
III to drive membrane scission, and also recycles ESCRT-
III subunits back into the cytosol13.
Loss of micronuclear compartmentalization exposes
DNA to the cytosol, which drives protective immune
responses14. Cytosolic DNA is recognized as foreign by
innate immune pathways involving cyclic GAMP synthase
(cGAS)15. cGAS binds to speciﬁc secondary structures
within exposed double and single-stranded DNA and
stimulates the production of 2′–5′ cyclic GMP–AMP
(cGAMP)16.
Here we present how ESCRT-III protects the genome
from the instability generated by micronuclei. We show
that ESCRT-III and VPS4 support micronuclear envelope
membrane integrity, mirroring their role in maintaining
the primary NE17. We also show that ESCRT-III activity is
aberrant at acentric collapsed micronuclei in unperturbed
cancer cells. We interpret this aberrant activity of ESCRT-
III as necessary for maintaining a population of ruptured,
cGAS-enriched micronuclei. Consistent with such a role,
this pool of collapsed micronuclei containing ESCRT-III,
cGAS and ssDNA is maintained by an apparent impair-
ment in ESCRT-III recycling and is removed by pre-
venting ESCRT-III recruitment at the NE.
Results
Depletion of CHMP7 or VPS4 compromise the NE but
damage DNA in different fashion
ESCRT-III helps to re-form the NE during cell division
and repairs the NE during interphase7,9,10,18. To further
understand the impact of ESCRT-III on NE integrity in
micronuclei, we ﬁrst performed a detailed analysis of the
phenotypes observed at interphase nuclei when ESCRT-
III activity is impaired. We depleted CHMP7 (Supple-
mental Fig. 1A, B), which initiates NE-associated ESCRT-
III assembly11, and VPS4 (Supplemental Fig. 1C and see
Methods), which regulates ESCRT-III-mediated
membrane-remodeling activity17.
Depletion of CHMP7 or VPS4 increased the frequency
of multinucleated cells (Supplemental Fig. 1D) and
increased the proportion of deformed interphase nuclei
(Supplemental Fig. 1E), conﬁrming their functional
knockdown19. Focusing on the role of ESCRT-III in NE
sealing, we observed defects in NE structure within
interphase nuclei. Consistent with CHMP7-initiating NE
sealing, depletion of this protein generated gross defects in
the nuclear lamina, including honeycomb-like and her-
niated breaks (Fig. 1a, b). VPS4 depletion did not generate
such severe abnormalities (Fig. 1b), but resulted in dis-
continuities in lamin B staining. These discontinuities
were enriched for CHMP7, as well as lamin A/C and LAP2
(Fig. 1c–e), indicating enrichment in membrane with
CHMP7 accumulations. Large CHMP7 accumulations
were seen in >80% of VPS4-depleted cells (Fig. 1f, g), but in
only <1% of interphase untreated or control-treated cells.
CHMP7 accumulations in VPS4-depleted cells also con-
tained CHMP4B (Fig. 1f, h), whereas CHMP4B was absent
when cells were co-depleted for VPS4 and CHMP7 (Fig.
1h), in agreement with CHMP7 coordinating the recruit-
ment of CHMP4B at the NE.
Consistent with their function at the NE, CHMP7 or
VPS4 depletion caused a loss of nuclear compartmenta-
lization, as revealed by the presence in the cytoplasm of
ProMyelocytic Leukemia (PML) bodies20 (Supplemental
Fig. 2A, B). In addition, h-TERT human ﬁbroblasts
depleted of CHMP7 displayed an increased cytosolic
distribution of a general nuclear import marker (GFP-
NLS, Supplemental Fig. 2A, C and Supplemental Fig. 1F).
CHMP7 and VPS4 depletion generated substantial
DNA damage as assessed by staining with γH2AX, a
marker for double-strand breaks21,22. Upon CHMP7
depletion (Supplemental Fig. 2D), γH2AX stained abun-
dant foci throughout the nucleus, which were large
compared with the rare γH2AX foci seen in control cells
(Supplemental Fig. 2E, F). Abundant γH2AX foci were
also seen in VPS4-depleted cells (Supplemental Fig. 2E),
nevertheless these were generally smaller than those seen
in CHMP7-depleted cells (Supplemental Fig. 2F), and
conﬁned towards the nuclear periphery surrounding large
CHMP7 accumulations (Supplemental Fig. 2G top
panels). CHMP7 foci in VPS4-depleted cells also labeled
for the DNA repair markers Rad51 and RPA (Supple-
mental Fig. 2G, H), indicating the presence of single-
stranded DNA (ssDNA)23.
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Fig. 1 CHMP7 and VPS4 depletion cause general nuclear envelope disorganization. a Examples of the honeycomb and herniated Lamin A and
B phenotypes in HeLa cells treated with CHMP7 sRNAi for 48 h. Arrowheads indicate chromatin protruding out the nucleus in herniated cells. b
Quantiﬁcation of Lamin A and B defects in Hela cells treated with the indicated sRNAi (minimum of 300 cells scored per condition). c Examples of
CHMP7 foci in HeLa cells treated with VPS4 and NT-control sRNAi for 48 h and associated with LAP2 or Lamin A foci (LAP2 and Lamin A enriched,
arrowheads) or associated with Lamin B holes (HeLa M). d Average CHMP7 foci number per nucleus in HeLa (n= 305), HeLa M (n= 222), and U2OS
(n= 257) cells treated with VPS4 sRNAi for 48 h. e Quantiﬁcation of CHMP7 foci in relation to LAP2, Lamin A/C, or Lamin B, in HeLa cells treated with
VPS4 sRNAi for 48 h (minimum of 400 foci for each condition). f Deconvolved wideﬁeld image of CHMP4B co-localization with CHMP7 at nuclear
envelope foci in HeLa cells transfected with VPS4 sRNAi for 48 h (top panel) and CHMP7/CHMP4B distribution in control cells (bottom panel). g
Percentage of HeLa cells containing at least one large accumulation of CHMP7 (focus) following VPS4 sRNAi treatment at 24, 48, and 72 h post
transfection (minimum of 200 nuclei scored for each condition). h Number of nuclear CHMP foci accumulating in HeLa M cells under the indicated
sRNAi treatments. (minimum of 100 nuclei scored for each condition). Averages and SEM are shown (N= 3). Scale bars represent 10 μm
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Overall, these data reﬂect the difference between coor-
dination of recruitment (CHMP7) and dynamics of
ESCRT-III assembly (VPS4) at the NE7,9,10. CHMP7-
depleted cells are defective in NE assembly and show
widespread lamina disorganization, rupture and DNA
damage. In contrast, VPS4 depletion induces aberrant
ESCRT-III accumulations that associate with localized NE
membrane enrichment and ssDNA.
Loss of ESCRT-III activity increases micronuclei with
compromised envelope membranes in interphase
Cells displaying chromosomal instability are character-
ized by micronuclei, which are generated when lagging
chromosomes or chromosome fragments are enveloped
by NE membranes. Lagging DNA arises directly from
kinetochore-microtubule attachment errors during mito-
sis (aneugenic mechanisms), as well as an indirect con-
sequence of unrepaired DNA damage during previous cell
cycles that generated chromosome fragments (clastogenic
mechanisms)21,24,25. Given the roles of ESCRT-III at the
nucleus, mitosis and cell division10,18,26,27, we assessed the
impact of impairing ESCRT-III function on the incidence
of micronuclei with ruptured envelopes.
Depletion of CHMP7 and/or VPS4 resulted in at least
approximately twofold increase in the population of cells
containing micronuclei (Fig. 2a, b) and a modest increase
in the number of micronuclei per micronucleated cell
(Fig. 2c). Micronuclei arising from clastogenic events28,29
are acentric, whereas micronuclei arising from aneugenic
events contain whole chromosomes and therefore contain
centromeres. Approximately 50% of micronuclei in con-
trol cells contained centromeres, as assessed by staining
for the centromeric marker CREST. This proportion
changed only slightly upon depletion of either CHMP7 or
VPS4, albeit with opposite tendencies (Fig. 2d). Hence, the
increase in micronuclei resulting from ESCRT-III deple-
tion most likely arises via a combination of aneugenic and
clastogenic mechanisms.
We then examined lamin B staining to assess the impact
of ESCRT-III disruption on the NE of micronuclei.
Depletion of VPS4 or CHMP7 increased the proportion of
micronuclei in which the lamina was absent or dis-
continuous (Fig. 2e; Supplemental Fig. 3A), recapitulating
the phenotype observed at the primary nucleus. Micro-
nuclei lacking nuclear pore complexes (NPCs) may be
unable to import lamins, and indeed the density of NPCs
at micronuclei, assessed by mab414 staining (Supple-
mental Fig. 3B, C), was reduced upon VPS4 or CHMP7
depletion (Fig. 2f). Disruption of NE architecture can lead
to invasion of the endoplasmic reticulum (ER) into the
micronucleus core2. Depletion of CHMP7 or VPS4
increased ER invasion, as assessed by intense labeling of
micronuclei with the lumenal ER marker Protein Disulﬁde
Isomerase (PDI) (Figs. 2g and 5a, c). Moreover, fewer
micronuclei in CHMP7 or VPS4-depleted cells labeled for
the soluble nuclear enzyme PARP1 (Fig. 2h) or for GFP-
NLS (Fig. 2i, j), indicating compromised compartmenta-
lization. In summary, loss of ESCRT-III function pro-
motes formation micronuclei that largely show impaired
NE integrity.
ESCRT-III accumulates within a subset of micronuclei
Interestingly, we observed a signiﬁcant enrichment of
ESCRT-III proteins at the NE of micronuclei in unper-
turbed cells. Therefore, we examined the morphology of
the structures that displayed localization of endogenous
ESCRT-III. ESCRT-III residency at the reforming NE of the
primary nucleus is dynamic and short-lived10, such that
large ESCRT-III accumulations are very rarely detected at
the interphase nucleus at steady state but are observed in
>80% cells when VPS4 is depleted (Fig. 1h). To our sur-
prise, however, we found that at micronuclei the situation is
strikingly different. Speciﬁcally, intense CHMP7 labeling
(CHMP7+ ve) was found on ~ 20–25% of micronuclei in
non-treated or control-treated cells (Fig. 3a–c), revealing an
accumulation never seen at the primary nucleus and
pointing towards a potential dysfunction of ESCRT-III at
micronuclei. CHMP7 labeling of micronuclei was observed
at a similar frequency across several cancer cell lines (Fig.
3b). CHMP7-labeled micronuclei also stained strongly for
CHMP4B (Fig. 3a, d). Whereas CHMP7 labeling was con-
ﬁned to peripheral puncta upon VPS4KD (Supplemental
Fig. 2G), Stimulated emission depletion microscopy (STED)
revealed that in most (32/35) micronuclei that labeled for
ESCRT-III, the staining localized deep within the micro-
nucleus core (Fig. 3d, e). When VPS4 was depleted, the
population of CHMP7-enriched micronuclei rose to ~ 60%
(Fig. 3d). Thus, an additional pool of ESCRT-III associates
dynamically ESCRT-III with micronuclei, consistent with
ESCRT-III mediated repair (Fig. 2). Recruitment of
CHMP4B to micronuclei, both in the presence and absence
of VPS4, depended on CHMP7 (Fig. 3c). Hence, both
dynamic and persistent pools of ESCRT-III at micronuclei
assemble in similar order to that observed at the primary
nucleus.
ESCRT-III enriched micronuclei lack NE integrity and
nuclear compartmentalization
Overall, these data suggest that ESCRT-III associates
with micronuclei dynamically, presumably as part of a
repair process, but also point towards a dramatic retention
of ESCRT-III under normal conditions at a subset of
micronuclei. The deep penetration into micronuclei of
ESCRT-III accumulations potentially points to gross
structural defects in these structures. Indeed, whilst most
CHMP7-negative micronuclei had an intact (i.e., “con-
tinuous”) lamina, the lamina was either absent from or
discontinuous in virtually all CHMP7-positive micronuclei
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Fig. 2 Impairment of ESCRT-III function affects micronuclei integrity. a HeLa cells were transfected with the indicated sRNAi for 48 h and the
percentages of cells with at least one micronucleus were quantiﬁed for each treatment (minimum 250 cells per treatment, per repeat). Results were
analyzed using a one-way ANOVA with Dunnett’s post hoc test. b HeLa cells were transfected with the indicated sRNAi for either 24, 48, or 72 h. The
number of micronucleated cells were quantiﬁed for each one of the treatments (minimum 200 cells were scored for each treatment, per repeat).
Results were analyzed using a two-way ANOVA with Dunnett’s post hoc test. c The average number of micronuclei observed per micronucleated cell
were quantiﬁed (minimum 150 cells per treatment, per repeat). Results were analyzed using a one-way ANOVA with Dunnett’s post hoc test. d
Micronuclei in HeLa cells transfected for 48 h with the indicated sRNAi and scored for presence of CREST (minimum 200 micronuclei per treatment,
per repeat). Results were analyzed using a one-way ANOVA with Dunnett’s post hoc test. e HeLa cells were transfected with the indicated sRNAi for
48 h and scored for the status of Lamin B, as deﬁned in supplementary Figure 2A (minimum 100 micronuclei per treatment, per repeat). Results were
analyzed using a one-way ANOVA with Dunnett’s post hoc test. Statistics shown for the “absent” category. f HeLa cells were transfected with the
indicated sRNAi for 48 h and scored for the status of mab414, as deﬁned in supplementary Figure 2B (minimum 100 micronuclei per treatment, per
repeat). Results were analyzed using a one-way ANOVA with Dunnett’s post hoc test. Statistics shown for the ‘absent’ category. g Micronuclei in HeLa
cells transfected for 48 h with the indicated sRNAi and scored for presence of PDI within micronuclear chromatin (PDI-invaded; minimum 100
micronuclei per treatment, per repeat). Results were analyzed using a one-way ANOVA with Dunnett’s post hoc test. h Micronuclei in HeLa cells
transfected for 48 h with the indicated sRNAi and scored for presence of PARP1 (minimum 100 micronuclei per treatment, per repeat). Results were
analyzed using a one-way ANOVA with Dunnett’s post hoc test. Averages and SEM are shown (N= 3, unless stated otherwise). i HeLa cells treated
with control or CHMP7 sRNAi, then transfected with GFP-NLS post-seeding and imaged 48 h post sRNAi depletion. Examples of micronuclei with
GFP-NLS absent (top panel) or present (bottom panel) (arrowheads). Scale bar 10 μm. j Quantiﬁcation of GFP-NLS retention in micronuclei treated as
in g as judged visually by the loss of nuclear signal (25 micronuclei scored per treatment, per repeat). Averages of N= 2 biological repeats are shown
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(Fig. 4a, b and Supplementary Figure 3A). As expected,
when a discontinuous Lamin B was present, CHMP7
occupied several gaps in Lamin B staining (Fig. 4a).
We then quantiﬁed CHMP7-positive micronuclei
according to the density of NPCs. Most CHMP7-positive
micronuclei did not contain, or had reduced density, of
NPCs compared with CHMP7-negative micronuclei (Fig.
4c, d and Supplemental Fig. 3B). CHMP7-positive micro-
nuclei also rarely contained PARP1, in contrast to CHMP7-
negative micronuclei (Fig. 4e, f), highlighting a defect in
compartmentalization. Loss of NE integrity was not owing
simply to an absence of membrane, as all CHMP7-positive
micronuclei labeled for the NE marker LAP2, and indeed
labeled more strongly for this marker than CHMP7-
negative micronuclei or parent nuclei (Fig. 4g, h).
This ﬁnding prompted us to investigate if these micro-
nuclei are “collapsed” and hence their chromatin core is
invaded by NE/ER membrane2. Such micronuclear
envelope collapse is induced by nuclear lamina defects,
and this weakness is associated with catastrophic DNA
damage, genomic instability and inﬂammation3,14,30,31.
Indeed, ER membrane was enriched within the core region
of nearly all CHMP7-positive micronuclei in control and
VPS4-depleted cells, with the PDI signal much more
intense than over the rest of the cell (Fig. 5a–c). In con-
trast, only ~ 10% of CHMP7-negative micronuclei exhib-
ited a strong PDI signal intensity (Fig. 5a, b). In summary,
CHMP7 accumulates on micronuclei that have a disrupted
NE, and which are inﬁltrated with ER membrane.
Taken together, these data show that ESCRT-III accu-
mulates selectively on micronuclei that lack NE integrity
and recapitulate the phenotype occurring at the primary
nucleus when VPS4 is depleted. Thus, ESCRT-III activity
is impaired at a subset of micronuclei in interphase cells.
ESCRT-III accumulates preferentially to acentric
micronuclei containing fragmented DNA
ESCRT-III accumulates on a subset of micronuclei. To
determine whether these are derived primarily from
aneugenic or clastogenic events, we quantiﬁed the
Fig. 3 ESCRT-III accumulates on micronuclei and is recruited by CHMP7. a Untreated HeLa cells showing accumulations of CHMP7 and CHMP4B
at a micronucleus (arrowhead). Scale bars 10 µm. b U2OS, HeLa, and HeLa M cell lines were transfected with non-targeting or VPS4A and B sRNAi for
48 h, and stained for CHMP7. Micronuclei were scored for presence or absence of CHMP7 (minimum of 400 micronuclei scored per treatment). c
Percentage of micronuclei in HeLa cells transfected with the indicated sRNAi for 48 h displaying enriched CHMP7 or CHMP4 (minimum 200
micronuclei scored per treatment). d Confocal microscopy in STED mode of a micronucleus in a control HeLa cell containing CHMP7 and CHMP4B
accumulations. Scale bars represent 1 µm. e Confocal microscopy in STED mode of the micronucleus in d showing z-slicing across 335 nm starting
from the top going towards the inside of the micronucleus. Scale bar 1 μm. Averages and SEM are shown (N= 3)
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Fig. 4 Micronuclei with CHMP7 accumulations lack nuclear lamina integrity, nuclear pore complexes, and soluble nuclear proteins but are
enriched in LAP2. a Immunoﬂuorescence image of a micronucleus where CHMP7 localizes to regions with gaps in Lamin B in control cells (top
panel). Examples of CHMP7-positive (arrows) and negative (arrowheads) in control HeLa cells (bottom panel). Scale bar 3 µm. b Distribution of the
status of CHMP7 and Lamin B in micronuclei (minimum 100 micronuclei scored per repeat). c Examples of CHMP7-positive and negative micronuclei
with NPC staining in control HeLa cells. d Micronuclei in HeLa cells were scored for the status of CHMP7 and the status of NPC (mab414) within the
same micronucleus (minimum 160 micronuclei scored per repeat). e Examples of CHMP7-positive and negative micronuclei showing absence or
presence of PARP1 staining. Scale bar 3 µm. f Quantiﬁcation of the presence or absence of PARP1 and CHMP7 staining within the same micronucleus
(minimum 200 micronuclei scored per repeat). g Examples of CHMP7-positive and negative (arrowhead) micronuclei with LAP2 staining. Scale bar
3 µm. h Quantiﬁcation of the presence or absence of LAP2 and CHMP7 staining within the same micronucleus (300 micronuclei per repeat). Data
were analyzed using Fishers’ exact test on pooled raw counts distributions (N= 3)
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proportion of ESCRT-III micronuclei containing whole or
partial chromosomes, using CREST staining28. CHMP7-
labeled micronuclei mostly lacked CREST staining (Fig. 6a,
b). In contrast, most CHMP7-negative micronuclei labeled
for CREST (Fig. 6a, b). CHMP7-positive micronuclei were
also much smaller than CHMP7-negative micronuclei ( ~
1.5 μm in diameter on average compared with ~ 2.2 μm,
representing a ~ 50% smaller volume) (Fig. 6c), consistent
with them containing chromosome fragments.
UV-C irradiation is a clastogenic agent, generating
single-stranded DNA lesions that can lead via replication
stress to double-strand breaks32,33 and subsequent aber-
rant mitotic partitioning of chromosome fragments into
micronuclei, which accumulate ssDNA-binding proteins.
Therefore, to conﬁrm that ESCRT-III accumulates pre-
ferentially on micronuclei arising from DNA damage, we
used recovery from UV-C irradiation to selectively
increase this population of micronuclei. HeLa cells were
irradiated with a moderate dose of UV-C, and the number
and phenotype (i.e., labeling for CHMP7 and/or the
double-strand break marker γH2AX) of micronuclei were
analyzed over 72 h recovery. The number of micronuclei
per cell increased after 24 h and rose ~ 4-fold within 48 h
(Fig. 6d, e), a timing indicative of the need for cells to go
through mitosis in order to form micronuclei34. Aligned
with this increase, the proportion of micronuclei that
were CHMP7-positive also rose signiﬁcantly (Fig. 6f). As
expected, labeling of micronuclei for γH2AX also
increased, though here the pattern was more complex.
The population of γH2AX-positive micronuclei ﬁrst
increased modestly around 1 h post treatment, high-
lighting a minor population of pre-existing micronuclei
that are directly subject to DNA damage (Fig. 6g). A
second, larger increase in the proportion of micronuclei
labeled for γH2AX, and for both CHMP7 and γH2AX,
was apparent over 24–48 h (Fig. 6g, h).
In summary, acentric micronuclei are preferentially
enriched by ESCRT-III; consistent with this, clastogenic
agents such as UV21,22,30,35,36 increase the population of
micronuclei that contain ESCRT-accumulations.
CHMP7 is important for generating ssDNA and retaining
cGAS to a pool of micronuclei
Collectively, our data point to a pool of ESCRT-III that
preferentially accumulates on micronuclei lacking NE
integrity and compartmentalization. However, ESCRT-III is
not the primary cause of these defects in micronuclear
organization, as they are more frequent when ESCRT-III
function is lacking. As damage to micronuclei can generate
a source of immunostimulatory DNA14, we next examined
the role of ESCRT-III in this downstream process. Micro-
nuclei enriched for CHMP4B preferentially stained strongly
for replication protein A (RPA), a protein that binds directly
to ssDNA (Fig. 7a, b). Similarly, cGAS, is known to enter
ruptured micronuclei to bind exposed DNA and indeed was
concentrated in nearly all those accumulating CHMP7 (Fig.
7c, d). Signiﬁcantly, CHMP7 depletion reduced the pro-
portion of micronuclei that were enriched for RPA (Fig. 7e,
Fig. 5 Micronuclei with ESCRT-III accumulations display ER membrane invasion. a Examples of CHMP7-positive and negative micronuclei with
PDI staining. PDI-excluded micronuclei have endoplasmic reticulum (ER) membrane surrounding their boundaries but not in the micronuclear
interior. PDI-invaded micronuclei show ER membrane inside the micronuclear boundary, indicating nuclear envelope collapse (arrowheads). b
Distribution of the status of CHMP7 and the presence or absence of PDI invasion within the same micronucleus (minimum 100 micronuclei scored
per repeat). Data were analyzed using Fishers’ exact test on pooled raw counts distributions (N= 3). c Example image of a micronucleus in a Hela cell
after treatment with VPS4 sRNAi for 48 h. Accumulation of PDI and CHMP7 within the micronucleus and the irregular shape display membrane
inﬁltration (arrowhead). Scale bars 3 µm
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Fig. 6 ESCRT-III preferentially accumulates on acentric micronuclei. a HeLa cells transfected with either control or VPS4 sRNAi for 48 h hours and
co-stained for CREST to detect centromeres, CHMP7, and DAPI. Examples of CHMP7+ ve micronuclei that are CREST+ ve (arrowhead indicating
weak CREST signal) or CREST-ve (arrowhead indicating the absence of CREST signal). Scale bars 10 µm. b Quantiﬁcation of micronuclei in HeLa cells
containing at least one deﬁnite CREST foci which resembles those found in the primary nucleus and CHMP7 (minimum 200 micronuclei scored per
repeat). Results were analyzed using a Fishers exact test on pooled data. Individual biological repeats were also signiﬁcant to Fishers exact (p < 0.05). c
Control HeLa cells were stained for CHMP7 and DAPI. The diameter of micronuclei measured in ImageJ (75 CHMP7-positive and 75 CHMP7-negative
micronuclei). HeLa cells were transfected with sRNAi for 48 h and stained to show CREST, CHMP7, and DAPI. d–h HeLa cells were treated with a
10 mJ/cm2 dose of UV-C irradiation and ﬁxed at various timepoints following treatment. The cells were stained for γH2AX, CHMP7, and DAPI. d
Accumulations of CHMP7 and γH2AX within a single micronucleus in control cells and in cells 24 and 48 h post recovery from UV-C (scale bar 10 µm).
The number of micronuclei per cell post UV-C treatment is shown in e. Micronuclei were scored for presence of f CHMP7 accumulation and g γH2AX
foci, with micronuclei containing at least one focus being considered as positive (400 cells per treatment). The percentage of micronuclei positive for
both γH2AX and CHMP7 are shown in h. The percentage is calculated against the total number of micronuclei counted for each time point, varying
between a minimum of 50 and a maximum of 285. Averages and SEM are shown (N= 3). Results were analyzed using a one-way ANOVA with
Dunnett’s post hoc test
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f) or cGAS (Fig. 7g, h). In contrast, VPS4KD did not
appreciably affect RPA or cGAS enrichment at micronuclei
(Fig. 7e–h), despite its negative impact on micronuclear
integrity (Supplemental Fig. 2B and Fig. 2H).
In summary, the co-enrichment of ESCRT-III and RPA/
cGAS at a subset of micronuclei and the absence of RPA/
cGAS enrichment upon CHMP7 depletion, point to a
non-canonical (VPS4-independent) function for ESCRT-
III in maintaining a pool of cytosolic DNA in cancer cells.
Discussion
We have addressed how the ESCRT-III
membrane–repair complex supports genomic stability
via its effects on aberrant structures associated with
chromosomal instability and genotoxic events, namely
micronuclei. Micronuclear collapse contributes to the
accumulation of damaged DNA arising as a result of NE
rupture, increasing the likelihood of failed DNA replica-
tion and persistent genomic instability. Therefore, the
Fig. 7 (See legend on next page.)
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existence of a mechanism for protecting the DNA within
micronuclei is plausible, in order to avoid chromosome
shattering and chromothripsis3,37.
Whereas the process of reformation of a micronuclear
envelope is not well understood, almost 100% of sponta-
neously arising micronuclei display successful nucleocy-
toplasmic compartmentalization upon exit from mitosis2.
These micronuclei must have a sealed NE, a process
carried out at the primary nucleus by the CHMP7/
ESCRT-III/VPS4 system17. Indeed, ESCRT-III dynamics
at lagging chromosomes during telophase appears nor-
mal38. We show here that loss of CHMP7 or VPS4 leads
to increased occurrence of micronuclei with a ruptured
and collapsed NE, supporting a role for ESCRT-III in
sealing micronuclear envelopes (Supplemental Fig. 4A).
Importantly, however, our data also highlight a popu-
lation of ESCRT-III that apparently is not subject to rapid,
VPS4-dependent turnover, which accumulates within
micronuclei (Supplemental Fig. 4B). Two questions arise:
what mechanisms lead to the generation of this “persis-
tent” pool of ESCRT-III, and does the pool have a selec-
tive role at micronuclei that is distinct from membrane
repair?
To identify events that lead to ESCRT-III accumulations
on micronuclei, we have comprehensively characterized
the nature of these structures. Most have a broken lamina
and are inﬁltrated by ER membranes, with a consequent
loss of compartmentalization. These phenotypes are more
rarely observed in micronuclei that lack CHMP7. Such
defects might be owing to aberrant micronuclear NE
assembly after mitosis5 and/or failure to repair a ruptured
micronuclear NE during interphase2.
At the primary nucleus, the recruitment of ESCRT-III is
so transient7,10 that depletion of VPS4 is necessary to slow
down ESCRT-III turnover at the membrane (VPS4-
dependent pathway, Supplemental Fig. 4A). Our VPS4KD
data imply the existence of a similar mechanism; hence,
the accumulation of CHMP7 and CHMP4B at micro-
nuclei observed in unperturbed cancer cells implies the
normal balance between ESCRT-III assembly and dis-
assembly is impaired and/or is not regulated by VPS4
(VPS4-independent pathway, Supplemental Fig. 4B).
ESCRT-III-enriched micronuclei are smaller than those
lacking ESCRT-III and are predominantly acentric; they
therefore most likely contain chromosome fragments, such
as those generated by DNA damage in previous cell
cycles39. Hence, ESCRT-III accumulation might result from
aberrant NE formation around chromosomal fragments, in
which the NE membrane is subject to an unusually high
degree of curvature and is prone to rupture40. One
potential explanation for impaired ESCRT-III turnover at
acentric micronuclei could be the lack of a regulatory
activity that relies on signaling from the centromere.
Steric conﬁnement provided by dense spindle micro-
tubules at telophase causes uneven loading of NE proteins
on lagging chromosomes, consequently generating
micronuclei with a defective NE38. This phenomenon
explains why such micronuclei may spontaneously rup-
ture later in interphase; therefore, it is possible that
ESCRT-III is recruited to micronuclei arising from this
pathway.
Is there a role for aberrant ESCRT-III accumulations?
ESCRT-III enrichment at micronuclei may cause further
damage to DNA (Supplemental Fig. 4B), as suggested by
the signiﬁcant association between ESCRT-III and RPA,
which marks the presence of single-stranded DNA41. Both
RPA and cGAS enrichment in micronuclei are lost by
depleting CHMP7 but not VPS4 (Fig. 7), arguing that the
(see ﬁgure on previous page)
Fig. 7 CHMP7 is important for generating damaged DNA at micronuclei. a Control HeLa cells containing micronuclei positive or negative for
RPA70 and CHMP4B. Top panel: the arrowheads show micronuclei negative for RPA70 and CHMP4B. Bottom panel: the arrowheads show micronuclei
positive for RPA70 and CHMP4B. Scale bar 3 µm. b Micronuclei, in control HeLa cells, scored for the status of CHMP7 and for presence or absence of
single-stranded DNA (RPA70) within the same micronucleus (minimum 115 micronuclei scored per repeat). Data analyzed using Fishers’ exact test on
pooled raw counts distributions (N= 3). c Control HeLa cells with micronuclei positive or negative for cGAS and CHMP7. Top panel: the arrowheads
show micronuclei positive for cGAS (red) and CHMP7 (green). Bottom panel: the arrowheads show micronuclei negative for cGAS (green) and CHMP7
(red). Scale bar 3 µm. d Micronuclei, in control HeLa cells, scored for the status of CHMP7 and the presence or absence of cGAS within the same
micronucleus (minimum 150 micronuclei scored per repeat). Data analyzed using Fishers’ exact test on pooled raw counts distributions (N= 3). e
Micronuclei from HeLa cells transfected for 48 h with the indicated siRNA and scored for enrichment in RPA70 signal (minimum 50 total micronuclei
scored per treatment, per repeat). Results were analyzed using a one-way ANOVA with Dunnett’s post hoc test. Averages and SEM shown (N= 3). f
Top panel: HeLa cells depleted of CHMP7 for 48 h (arrowheads show RPA70+ ve micronuclei; ﬁlled arrowheads show RPA70-ve micronuclei). Bottom
panel: HeLa cells depleted of VPS4 for 48 h (arrowheads show RPA70+ ve and CHMP4B+ ve micronuclei). Scale bar 10 μm. g Micronuclei in HeLa
cells transfected for 48 h with the indicated siRNA and scored for enrichment in cGAS signal (minimum 55 micronuclei scored per treatment, per
repeat). Results analyzed using a one-way ANOVA with Dunnett’s post hoc test. Averages and SEM shown (N= 3). h Top panel: HeLa cells depleted of
CHMP7 for 48 h (arrowheads show cGAS+ ve micronuclei; ﬁlled arrowheads show cGAS-ve micronuclei). The CHMP7 channel is 3× over-exposed to
highlight the absence of CHMP7 accumulations on the micronuclei. Bottom panel: HeLa cells depleted of VPS4 for 48 h (arrowhead shows a cGAS+
ve micronucleus; arrow shows cGAS enrichment at a CHMP7 nuclear accumulation). Scale bar 10 μm. f and h the exposure time has been adjusted to
compensate for varying intensity of the signals between CHMP7 and VPS4 knockdown experiments
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accumulation of ESCRT-III is required to generate higher
levels of damaged DNA (Supplemental Fig. 4B).
The implications for aberrant NE remodeling by
ESCRT-III at micronuclei may be far further reaching
than simply explaining a genome predisposition to
aneuploidy19,42 or chromothripsis caused by loss of NE
repair activity.
Ruptured micronuclei are key signals to activate
immune pathways that can control tumor progression14,43
via the cGAS-STING (STimulator of Interferon Gene)
pathway14. cGAS recognition drives immune responses,
senescence44,45 and the elimination of cytosolic DNA by
autophagy46. The ESCRT-III subunit CHMP4B was pre-
viously localized at micronuclei and a link with autop-
hagic degradation of cytosolic DNA was suggested47.
CHMP7 depletion decreases the population of cGAS-
enriched micronuclei. The observed reduction is similar
in magnitude to the proportion of micronuclei with
ESCRT-III accumulations in unperturbed cells ( ~ 20%).
This suggests that ESCRT-III supports cGAS in ruptured
micronuclei, perhaps by enhancing the production of
DNA structures recognized by cGAS14,16. It is unlikely
that CHMP7 depletion simply creates unstable micro-
nuclei that lose cGAS, as VPS4 depletion does not reduce
either the pool of RPA or cGAS-enriched micronuclei
even though VPS4-depleted cells show loss of compart-
mentalization (Supplemental Fig. 2B and Fig. 2H).
In the context of cancer progression, short-lived cGAS
signaling may be beneﬁcial to induce antitumor responses;
conversely, it may contribute to cancer progression if
persistently sustained48. Higher CHMP7 and cGAS44 RNA
expression correlate with higher frequency of patient
survival in lung adenocarcinoma (Supplemental Fig. 4C,
D), a tumor with high levels of chromosomal instability2,48.
Moreover, CHMP7 has been identiﬁed as gene that
negatively regulates cell proliferation (STOP gene), in a
study showing how recurrent deletions occurring in can-
cers drive tumorigenesis49. The CHMP7 gene is located on
the short arm of chromosome 8 (8p21.3). Chromosomal
deletions on this region are common in carcinomas50–54
and loss of heterozygosity in 8p regulates tumor progres-
sion and drug resistance55. Therefore, it is intriguing to
speculate that among the functions of ESCRT-III there is a
role for aberrant membrane-remodeling activity that
damages DNA, expose it to the cytosol, thus promoting
the activation of proinﬂammatory pathways that modulate
the tumor microenvironment.
Methods
Cell lines, transfections, and sRNAi knockdowns
HeLa, HeLa M, U2OS, and h-TERT cells were cultured
in Dulbecco's Modiﬁed Eagle Medium (DMEM, Life
Technologies) supplemented with 10% fetal bovine serum
and 1% non-essential amino acids (Lonza). Cells were
mycoplasma-free, with regular checks performed using
the Mycoalert Mycoplasma Detection Kit (Lonza).
Depletion of target proteins was carried out using
DHARMAFECT and ON-TARGETplus sRNAis per
manufacturer’s instructions (Thermo Scientiﬁc: Dharma-
con Products, Lafayette, CO, USA) (see Supplementary
Table 1 for sRNAi sequences). Cells were plated 24 h prior
to knockdown, transfected once with sRNAi for 24–72 h
at the appropriate concentration (usually 20 nM otherwise
stated) dissolved in serum-free DMEM. The efﬁciency of
sRNAi depletion was assessed by immunoblotting or
quantitative PCR.
To visualize GFP-NLS in CHMP7 knockdown experi-
ments, HeLa and h-TERT-immortalized Human Fibro-
blast cells were transfected with sRNAi CHMP7 20 nM19
or control sRNAi (GLi2 20 nM)56 24 h after seeding, then
transfected with 1 μg pEGFP-NLS(SV40) (Kind gift from
Dr. Patrizia Lavia) and ﬁxed at 48 h post transfection.
Quantitative PCR
Quantitative PCR was used to assess VPS4A depletion
in HeLa cells57. In brief, RNA was puriﬁed from cell
pellets using the Absolutely RNA Microprep kit (Strata-
gene). First-strand cDNA was synthesized using random
primers with the Multiple Temperature cDNA Synthesis
Kit (Stratagene). Samples were stored at -20 °C. RT-qPCR
was performed using the SYBR-GREEN JumpStart Taq
Ready Mix (Sigma). Conditions used were: initial dena-
turation at 94 °C for 2 min, followed by 40 cycles of
denaturation at 94 °C for 15 s, annealing at 53.7 °C for
1 min, 72 °C for 1 min. Tata Binding Protein (TBP) was
used as a loading control for the qPCR.
TBP ampliﬁcation primers: forward, 5′-GCCCGAAAC
GCCGAATATAATCCC-3′; reverse, 5′-GGACTGTTCT
TCACTCTTGGCTCCTG-3′. VPS4A primers: forward,
5′-GACAACGTCAACCCTCCAG-3′; reverse, 5′-AGC
GCCTCCTCGTAGTTCTT-3′.
Depletion of VPS4A was ~ 98% effective as judged by
RT-PCR.
Immunoﬂuorescence microscopy
Cells were ﬁxed with 4% paraformaldehyde for 15 min
at room temperature and permeabilized with 0.5% Triton
X-100 for 20min. Primary (Supplementary Table 2) and
secondary antibodies were incubated in 1% bovine serum
albumin in phosphate-buffered saline containing 0.1%
Triton X-100 in a humidiﬁed chamber at 4 °C. Coverslips
were mounted with VECTASHIELD (Vector Labora-
tories) or ProLong Gold (Invitrogen) mounting medium
containing 1.5 μg/ml DAPI. Fluorescence was detected
using a Nikon Eclipse TE200 microscope with × 60 or ×
100 objectives. Images were acquired using a Hamamatsu
C4742-96-12G04 digital CCD camera and Volocity ima-
ging software (Perkin Elmer), and analyzed using FiJi58.
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An Applied Precision Deltavision deconvolution micro-
scope with a UplanSApo × 100 oil (NA 1.4) objective and a
Photometrics CoolsnapHQ CCD camera was used to obtain
3D images. Z-slices were taken at 200 nm increments.
Image acquisition was carried out using SoftWoRx
v6 software, and deconvolution using Resolve 3D software
at recommended settings. Images were analyzed using FiJi58.
STED microscopy
STED images of cells stained with To-Pro3 (Thermo-
ﬁsher) or Abberior STAR- (Abberior GmbH, Germany),
Alexa Flour- or Oregon Green- (ThermoFisher Scientiﬁc,
Australia) conjugated secondary antibodies diluted 1:300
were acquired with a Leica TCS SP8 microscope (Leica
Microsystems GmbH, Mannheim, Germany) using a
Leica HCPL Apo × 100/1.40 oil STED white objective, and
equipped for 3D-gated- STED microscopy with a white
light laser (tunable from 470 nm to 670 nm) for excitation,
775 nm and 592 nm lasers for STED depletion and Hybrid
Detectors. STED lasers were operated at 50% output
power. Emitted ﬂuorescence was ﬁltered using notch ﬁl-
ters (775, 592, or 488 nm). Images were acquired using
sequential scanning with a line average of 2, a frame
accumulation of 3, and a scan speed of 600 Hz. Images
contained 1024 × 1024 pixels. Pixel size was 25 nm (X, Y)
and 67 nm (Z). Each z series (with sections at 67 nm
intervals) was acquired using Leica Application Suite
(LAS), then deconvolved using Huygens Professional
software (Scientiﬁc Volume Imaging, The Netherlands).
Images were analyzed using LAS and FiJi58.
Micronuclei scoring
Micronuclei from random ﬁelds of view in unsynchro-
nized, untreated or sRNAi-treated cells were scored for
enrichment in CHMP7 or CHMP4B and for a second
marker. Only interphase, non-apoptotic cells were ana-
lyzed (cells containing > 3 micronuclei were excluded to
further minimize the possibility of including apoptotic
cells). Micronuclei were deﬁned by criteria based on
Fenech et al.59: their diameter should not exceed 1/3 that
of the primary nucleus; they should be separated from the
primary nucleus; they should have similar intensity of
DAPI staining to the primary nucleus but occasionally
may stain more intensively. Micronuclei were identiﬁed
ﬁrst by DAPI staining and were then scored for the pre-
sence or absence of CHMP7, appearing as an intense pan-
micronuclear signal or large foci. Other phenotypes were
quantiﬁed based on visual assessment of various markers,
with ﬂuorescence intensity over the primary nucleus
taken as a reference where appropriate.
Statistical analysis of micronuclei categories
Data were analyzed as in Hatch et al.2. In brief, the
statistical difference between two or more categories of
micronuclei was determined using Fisher’s exact test (for
a 2 × 2 table) or x2 analysis on the raw counts to obtain a
p value. The Null hypothesis assumed was that all phe-
notypes occurred with the same frequency. The Cramer V
coefﬁcient (or ϕ coefﬁcient for a 2 × 2 table) was used to
assess the strength of association between variables. The
difference between independent replicates was deter-
mined by comparing p values for each individual experi-
ment. Raw counts were pooled and a ﬁnal p value
calculated if the p values of individual replicates resulted
in statistical signiﬁcance.
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